Interferon γ-Induced human guanylate binding protein 1 inhibits mammary tumor growth in mice

Molecular Medicine

Volumn 16, Issue 5-6, 2010, Pages 177-187

  Lipnik, Karoline ^a,b   Naschberger, Elisabeth ^c   Gonin Laurent, Nathalie ^c   Kodajova, Petra ^a   Petznek, Helga ^a   Rungaldier, Stefanie ^a   Astigiano, Simonetta ^d   Ferrini, Silvano ^d   Stürzl, Michael ^c   Hohenadl, Christine ^a  

^a UNIVERSITY OF VETERINARY MEDICINE   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^d UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DOXYCYCLINE; GAMMA INTERFERON; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANYLATE BINDING PROTEIN 1; HEMOGLOBIN; UNCLASSIFIED DRUG; VASCULOTROPIN A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; B LYMPHOCYTE; BREAST ADENOCARCINOMA; CANCER CELL; CANCER INHIBITION; CELL INFILTRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PARACRINE SIGNALING; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; WESTERN BLOTTING;

EID: 77951973346     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2009.00172     Document Type: Article

References (43)

1. Dunn GP, Koebel CM, Schreiber RD. (2006) Interferons, immunity and cancer immunoediting. Nat. Rev. Immunol. 6:836-48
2. Kim R, Emi M, Tanabe K. (2007) Cancer immunoediting from immune surveillance to immune escape. Immunology 121:1-14
3. Dighe AS, Richards E, Old LJ, Schreiber RD. (1994) Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFN gamma receptors. Immunity 1:447-56
4. Kaplan DH, et al. (1998) Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice. Proc. Natl. Acad. Sci. U. S. A. 95:7556-61
5. Kundu N, Beaty TL, Jackson MJ, Fulton AM. (1996) Antimetastatic and antitumor activities of interleukin 10 in a murine model of breast cancer. J. Natl. Cancer Inst. 88:536-41
6. Kundu N, et al. (1998) Interleukin-10 gene transfer inhibits murine mammary tumors and elevates nitric oxide. Int. J. Cancer 76:713-9
7. Sun H, Jackson MJ, Kundu N, Fulton AM. (1999) Interleukin-10 gene transfer activates interferon-gamma and the interferon-gamma-inducible genes Gbp-1/Mag-1 and Mig-1 in mammary tumors. Int. J. Cancer 80:624-9
8. Walser TC, et al. (2007) Immune- mediated modulation of breast cancer growth and metastasis by the chemokine Mig (CXCL9) in a murine model. J. Immunother. 30:490-8
9. Cheng YS, Colonno RJ, Yin FH. (1983) Interferon induction of fibroblast proteins with guanylate binding activity. J. Biol. Chem. 258:7746-50
10. Vestal DJ. (2005) The guanylate-binding proteins (GBPs): proinflammatory cytokine-induced members of the dynamin superfamily with unique GTPase activity. J. Interferon Cytokine Res. 25:435-43
11. Kresse A, et al. (2008) Analyses of murine GBP homology clusters based on in silico, in vitro and in vivo studies. BMC Genomics 9:158
12. Degrandi D, et al. (2007) Extensive characterization of IFN-induced GTPases mGBP1 to mGBP10 involved in host defense. J. Immunol. 179:7729-40
13. Olszewski MA, Gray J, Vestal DJ. (2006) In silico genomic analysis of the human and murine guanylate-binding protein (GBP) gene clusters. J. Interferon Cytokine Res. 26:328-52
14. Prakash B, Renault L, Praefcke GJ, Herrmann C, Wittinghofer A. (2000) Triphosphate structure of guanylate-binding protein 1 and implications for nucleotide binding and GTPase mechanism. EMBO J. 19:4555-64
15. Prakash B, Praefcke GJ, Renault L, Wittinghofer A, Herrmann C. (2000) Structure of human guanylate-binding protein 1 representing a unique class of GTP-binding proteins. Nature 403:567-71
16. Guenzi E, et al. (2003) The guanylate binding protein-1 GTPase controls the invasive and an-giogenic capability of endothelial cells through inhibition of MMP-1 expression. EMBO J. 22:3772-82
17. Guenzi E, et al. (2001) The helical domain of GBP-1 mediates the inhibition of endothelial cell proliferation by inflammatory cytokines. EMBO J. 20:5568-77
18. Naschberger E, Bauer M, Stürzl M. (2005) Human guanylate binding protein-1 (hGBP-1) characterizes and establishes a nonangiogenic endothelial cell activation phenotype in inflammatory diseases. Adv. Enzyme Regul. 45:215-27
19. Weinländer K, et al. (2008) Guanylate binding protein-1 inhibits spreading and migration of endothelial cells through induction of integrin alpha4 expression. FASEB J. 22:4168-78
20. Naschberger E, et al. (2008) Angiostatic immune reaction in colorectal carcinoma: impact on survival and perspectives for antiangiogenic therapy. Int. J. Cancer 123:2120-9
21. Gorbacheva VY, Lindner D, Sen GC, Vestal DJ. (2002) The interferon (IFN)-induced GTPase, mGBP-2: role in IFN-gamma-induced murine fibroblast proliferation. J. Biol. Chem. 277:6080-7
22. Nanni P, de Giovanni C, Lollini PL, Nicoletti G, Prodi G. (1983) TS/A: a new metastasizing cell line from a BALB/c spontaneous mammary adenocarcinoma. Clin. Exp. Metastasis 1:373-80
23. Ausserlechner MJ, Obexer P, Deutschmann A, Geiger K, Kofler R. (2006) A retroviral expression system based on tetracycline-regulated tricistronic transactivator/repressor vectors for functional analyses of antiproliferative and toxic genes. Mol. Cancer Ther. 5:1927-34
24. Agu CA, et al. (2006) The cytotoxic activity of the bacteriophage lambda-holin protein reduces tu-mour growth rates in mammary cancer cell xenograft models. J. Gene Med. 8:229-41
25. Naschberger E, et al. (2006) Human guanylate binding protein-1 is a secreted GTPase present in increased concentrations in the cerebrospinal fluid of patients with bacterial meningitis. Am. J. Pathol. 169:1088-99
26. Lubeseder-Martellato C, et al. (2002) Guanylate-binding protein-1 expression is selectively in-duced by inflammatory cytokines and is an activation marker of endothelial cells during inflammatory diseases. Am. J. Pathol. 161:1749-59
27. Zabala M, et al. (2004) Optimization of the Tet-on system to regulate interleukin 12 expression in the liver for the treatment of hepatic tumors. Cancer Res. 64:2799-804
28. Beckstead JH. (1994) A simple technique for preservation of fixation-sensitive antigens in paraffin-embedded tissues. J. Histochem. Cytochem. 42:1127-34
29. Beckstead JH. (1995) A simple technique for preservation of fixation-sensitive antigens in paraffin-embedded tissues: addendum. J. His-tochem. Cytochem. 43:345
30. Zeng G, Gao L, Birkle S, Yu RK. (2000) Suppression of ganglioside GD3 expression in a rat F-11 tumor cell line reduces tumor growth, angiogenesis, and vascular endothelial growth factor production. Cancer Res. 60:6670-76
31. Urruticoechea A, Smith IE, Dowsett M. (2005) Proliferation marker Ki-67 in early breast cancer. J. Clin. Oncol. 23:7212-20
32. Naschberger E, et al. (2004) Nuclear factor-kappaB motif and interferon-alpha-stimulated re-sponse element co-operate in the activation of guanylate-binding protein-1 expression by in-flammatory cytokines in endothelial cells. Biochem. J. 379:409-20
33. Baluk P, McDonald DM. (2008) Markers for microscopic imaging of lymphangiogenesis and angiogenesis. Ann. N. Y. Acad. Sci. 1131:1-12
34. Russo A, et al. (2005) Inhibition of granuloma-associated angiogenesis by controlling mast cell mediator release: role of mast cell protease-5. Br. J. Pharmacol. 145:24-33
35. Norrby K. (2006) In vivo models of angiogenesis. J. Cell Mol. Med. 10:588-612
36. Schroder K, Hertzog PJ, Ravasi T, Hume DA. (2004) Interferon-gamma: an overview of signals, mechanisms and functions. J. Leukoc. Biol. 75:163-89
37. Tripal P, Bauer M, Naschberger E, et al. (2007) Unique features of different members of the human guanylate-binding protein family. J. Interferon Cytokine Res. 27:44-52
38. Anderson S, Carton J, Lou J, Xing L, Rubin B. (1999) Interferon-induced guanylate binding protein-1 (GBP-1) mediates an antiviral effect against vesicular stomatitis virus and en-cephalomyocarditis virus. Virology 256:8-14
39. Persano L, et al. (2009) Interferon-alpha counter-acts the angiogenic switch and reduces tumor cell proliferation in a spontaneous model of pro-static cancer. Carcinogenesis 30:851-60
40. Harvat BL, Jetten AM. (1996) Gamma-interferon induces an irreversible growth arrest in mid-G1 in mammary epithelial cells which correlates with a block in hyperphosphorylation of retinoblastoma. Cell Growth Differ. 7:289-300
41. Jain RK. (2005) Normalization of tumor vasculature: an emerging concept in antiangiogenic ther-apy. Science 307:58-62
42. Jain RK. (2003) Molecular regulation of vessel maturation. Nat. Med. 9:685-93
43. Ellis LM, Hicklin DJ. (2008) VEGF-targeted therapy: mechanisms of anti-tumour activity. Nat. Rev. Cancer 8:579-91.